Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd

<< Previous

Bullboard Posts

Next >>

Post by sdhakaon Jan 09, 2024 4:48pm

186 Views

Post# 35818226

Initiates international expansion

Voyageur Pharmaceuticals Ltd. / TSXV: VM

PR Title

Initiates international expansion

FRC Opinion

Positive – VM has attracted an undisclosed global pharmaceutical distribution company to sell its barium contrast products. Contrast agents are administered before X-ray, MRI, or CT scans, to enhance image contrast by highlighting specific body structures. VM is aiming to commence commercial production in H1-2024.

read more: https://www.researchfrc.com/these-two-junior-resource-sectors-are-witnessing-a-surge-in-ma-financing-deals/https://www.researchfrc.com/these-two-junior-resource-sectors-are-witnessing-a-surge-in-ma-financing-deals/

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?